SCHEMBL26015372

SCHEMBL26015372

COC(C)Oc1ccccc1CC(C)C

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.44
GABRB2 P47870 1/20 0.44
AOC3 Q16853 1/20 0.40
KCNH2 Q12809 2/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.36
IDO1 P14902 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
ELANE P08246 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11991402 0.84 SLC6A2 (0.50) GABRA1GABRB2KCNH2SLC6A2SLC6A4
SCHEMBL878976 0.82 IDO1 (0.53) GABRA1GABRB2AOC3HPGDHTT
SCHEMBL10160283 0.81 SLC6A2 (0.48) GABRA1GABRB2KCNH2SLC6A2SLC6A4
SCHEMBL4575612 0.79 GABRA1 (0.50) GABRA1GABRB2SLC6A2SLC6A4HPGD
SCHEMBL15118684 0.79 MCHR1 (0.43) GABRA1GABRB2KCNH2SLC6A2SLC6A4
SCHEMBL9869223 0.78 TAAR1 (0.42) AOC3KCNH2IDO1TAAR1SIGMAR1
SCHEMBL363627 0.76 GABRA1 (0.52) GABRA1GABRB2SLC6A2SLC6A4HPGD
SCHEMBL27848472 0.76 GABRA1 (0.47) GABRA1GABRB2AOC3KCNH2SLC6A2
Propane SCHEMBL27634746 0.76 GABRA1 (0.47) GABRA1GABRB2SLC6A2SLC6A4CTSS
SCHEMBL2241620 0.76 GABRA1 (0.47) GABRA1GABRB2AOC3KCNH2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230266666-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230266666-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN H1-0, H1-4, CHRM1 GABRA1 1803/4885GABRB2 2702/4885AOC3 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.